Avience Biomedicals IPO Allotment Status & GMP Live

By Ms. Falguni SharmaUpdated
Avience Biomedicals IPO Allotment Status & GMP Live

The Avience Biomedicals IPO allotment status will be available on Tuesday, June 23, 2026. Investors can check their allotment status through the IPOwiz App, Skyline Financial Website, BSE, or their demat account. Below is a step-by-step guide to help you check your allotment status today.

Latest Grey Market Premium (GMP)

The grey market premium shows how investors feel about the IPO before listing. Here's how Avience Biomedicals IPO GMP stands currently:

Date IPO Price GMP Expected Listing Price
June 23 (Today) ₹208.00 ₹76.00 ₹284.00 (36.54%)

Based on the current GMP of ₹76.00, Avience Biomedicals IPO is expected to list around ₹284.00 per share, indicating a potential gain of 36.54% over the issue price.

Join us on Telegram: Click Here

Final Subscription in Avience Biomedicals IPO:

Category Subscription
Qualified Institutional Buyers 196.77x
Non-Institutional Investors 597.63x
Small HNI 451.35x
Big HNI 670.77x
Retail Investors 401.36x
Total 385.40x

The Avience Biomedicals IPO was subscribed 385.40 times overall, attracting strong demand from retail investors, HNIs, and institutional investors. Retail investors subscribed 401.36 times, resulting in highly competitive allotment chances.

Allotment Chances in Avience Biomedicals IPO:

Category Allotment Chances
Retail Investors 1 out of 401 applications
Small HNI 1 out of 404 applications
Big HNI 1 out of 214 applications

How to Check Avience Biomedicals IPO Allotment Status

Avience Biomedicals IPO allotment status will be available on Tuesday, June 23, 2026. Here's how you can check:

Option 1: Via IPOwiz App

  1. Download the IPOwiz App from the Play Store.
  2. Add the PAN numbers you want to check in the PAN section.
  3. Go to the Allotted Section and select Avience Biomedicals IPO.
  4. View the allotment status for the saved PAN numbers.

Option 2: Via Skyline Financial Website

  1. Visit the Skyline Financial IPO Allotment Page.
  2. Select Avience Biomedicals IPO from the drop-down menu.
  3. Enter your PAN number, application number, or demat account details.
  4. Click Search to view your allotment status.

Option 3: Via BSE Website

  1. Go to the BSE Website.
  2. Select Avience Biomedicals IPO from the list.
  3. Enter your PAN number, application number, or demat account details.
  4. Click Search to check your status.

Option 4: Via Demat Account

  • Log in to your demat or trading account.
  • Check if the allotted shares are credited from June 24, 2026 onwards.
  • If the shares are visible in your holdings, your allotment was successful.

What Happens After Allotment?

If you are allotted shares: Shares will be credited to your demat account on June 24, 2026. You can hold them for the long term or sell them on listing day, June 25, 2026. Based on the current GMP of ₹76.00, the estimated listing price is ₹284.00 per share.

If you are not allotted shares: Your blocked ASBA amount will be unblocked and refunded on June 24, 2026. UPI applications are automatically unblocked, while ASBA applications through net banking are processed by your bank.

On listing day: The stock is expected to list on June 25, 2026. Investors can sell allotted shares once trading begins.

Avience Biomedicals IPO Key Dates

  • IPO Open Date: June 18, 2026
  • IPO Close Date: June 22, 2026
  • Allotment Date: June 23, 2026
  • Refund Date: June 24, 2026
  • Demat Credit Date: June 24, 2026
  • Listing Date: June 25, 2026

Avience Biomedicals IPO Details

  • Price Band: ₹196 - ₹208
  • Issue Size: ₹30.24 Crore
  • Lot Size: 600 Shares
  • Minimum Investment: ₹2,49,600
  • IPO Type: NSE SME
  • Overall Subscription: 385.40x

About Avience Biomedicals

Avience Biomedicals Limited, incorporated in June 2024, is an ISO-certified healthcare and biotechnology solutions company. The company specializes in manufacturing, supplying, and exporting molecular diagnostic formulations, in-vitro diagnostics (IVD) rapid test kits, serology products, automated biochemistry analyzers, and hematology analyzers. Operating on B2B and B2G business models, Avience serves hospitals, pathology laboratories, healthcare institutions, and research organizations with cost-effective diagnostic solutions across India.

Registrar Details

Field Details
Registrar Skyline Financial Services Private Limited
Website skylinerta.com

FAQs

1. When will the Avience Biomedicals IPO allotment be out?
Avience Biomedicals IPO allotment will be available on June 23, 2026.

2. How to check Avience Biomedicals IPO allotment status?
You can check the allotment through IPOwiz App, Skyline Financial website, BSE, or your demat account.

3. What is the expected listing price of Avience Biomedicals IPO?
Based on the current GMP of ₹76.00, the estimated listing price is ₹284.00 per share.

4. What are the allotment chances for retail investors in Avience Biomedicals IPO?
Retail investors have approximately 1 out of 401 chances of receiving allotment.

5. When will shares be credited to demat accounts?
Shares will be credited to successful applicants on June 24, 2026.

6. When is Avience Biomedicals IPO listing date?
The shares are scheduled to list on June 25, 2026.

7. When will refunds be processed?
Refunds for unsuccessful applicants will be initiated on June 24, 2026.

8. Can I sell shares on listing day?
Yes, allotted shares can be sold when trading begins on June 25, 2026.

9. What should I do if I am not allotted shares?
Your blocked amount will be refunded on June 24, 2026. No action is required from your side.

10. Can I check allotment status using my PAN number?
Yes, PAN number is the easiest way to check allotment status through Skyline Financial, BSE, or IPOwiz App.

11. Who should I contact for allotment queries?
Contact Skyline Financial Services Private Limited through their official allotment portal for assistance.

For further queries, contact the IPO registrar, Skyline Financial Services Private Limited.

Advertisement
IPOStock MarketIPO AllotmentIPO NewsSME IPO
Loading comments...